CBSA to honor life science innovators, leaders tonight

Thursday November 9, 2017 0 comments Tags: Denver, CBSA, April Giles, Array BioPharma, miRagen Therapeutics, Sharklet Technologies, Cerescan, Eximis Surgical, Ocugen, Boettcher Foundation

DENVER -- Colorado BioScience Association (CBSA) will highlight “a banner year” marked by acquisitions, investments, discoveries and partnerships during its 14th Annual Awards Dinner tonight  in downtown Denver at the Hyatt Regency.CBSA_logoUSE

The event celebrates the companies, organizations and individuals who contribute to Colorado’s national reputation for innovation in life science, CBSA said.

As a highlight of the event, CBSA will announce the winners of the 2017 Company of the Year and Rising Star Awards. The awards honor companies for their achievements reaching significant milestones such as fundraising, commercialization and regulatory approvals.

“For the life science industry, 2017 brought significant fundraising, M&A activity and new breakthroughs to help people live healthier lives,” said April Giles, CBSA president and CEO.

“Our Company of the Year and Rising Star nominees represent the innovation underway in our state. From cutting-edge treatments for cancer to new ways to treat rare eye diseases, Colorado companies and institutions focus on advancing healthcare for people here in our state and around the world.”

This year’s Company of the Year nominees are:

Array Biopharma: Focusing on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

miRagen: Discovering and developing innovative microRNA-targeted therapies to address unmet medical needs and improve human health.

Sharklet Technologies: Creating and commercializing Sharklet®, the world’s first micro-texture that inhibits bacterial growth on surfaces.

Rising Star nominees include:

CereScan: Combining state-of-the-art brain imaging technologies with a patient-centered model of care to provide the highest level of neurodiagnostics available.

Eximis Surgical: Working to ease patient discomfort, provide safe outcomes and deliver on the promise of minimally invasive surgery.

Ocugen: Developing innovative therapies and novel biologics for rare and underserved ocular disorders.

Additional honorees include: Business Partner of the Year, Chairman’s Award, Volunteer of the Year, Educator of the Year, Institute Leadership and Legislator of the Year.

CBSA and the Boettcher Foundation will recognize the 2017 Class of Boettcher Investigators in the Webb-Waring Biomedical Research Awards program during the evening.

The program awards early-career investigators at Colorado’s research institutions with $235,000 in grant funding to sustain three years of biomedical research and honors them with the title of Boettcher Investigator.

The event is being held Nov. 9 at the Hyatt Regency Denver from 5-8:30 p.m. Sponsorships are $1,500 for a table of eight and $175 for an individual ticket.

For more information, click here.